![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals Reports Second Quarter and Six Month 2012 Financial Results and HCV Program Update
August 08, 2012 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals Prices Public Offering of Common Stock
August 02, 2012 09:22 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock
July 31, 2012 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., July 31, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals Announces Restructuring of Development and Commercialization Collaboration With Novartis Pharma AG
July 31, 2012 07:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., July 31, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
July 25, 2012 08:30 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., July 25, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
July 03, 2012 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., July 3, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the 7th Annual JMP Securities...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Announces Positive Clinical Data for HCV Drug Candidates IDX184 and IDX719
June 19, 2012 16:06 ET
|
Idenix Pharmaceuticals
In an Interim Analysis From an Ongoing Phase IIb Clinical Trial of IDX184, an HCV Nucleotide Inhibitor, 89% of Patients Who Completed an Additional 12 Weeks of Pegylated Interferon Plus Ribavirin...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals to Present at the Wells Fargo Securities 2012 Healthcare Conference
June 13, 2012 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., June 13, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will participate in a fireside chat at the Wells Fargo...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals Reports First Quarter 2012 Financial Results and HCV Development Program Progress
May 02, 2012 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., May 2, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
April 30, 2012 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., April 30, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc., (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Deutsche Bank 37th...